SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention is centered on SELLAS CEO Angelos Stergious comments that rigorous, unblinded REGAL data will resolve growing speculation as the Phase 3 AML trial approaches its final 80-event trigger, alongside favorable remarks from healthcare-industry executives about GPS. Traders remain divided between optimism that the 80th event and readout are imminent and bearish concerns about trial design and the still-unconfirmed event count, officially last reported at 78 of 80.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

Hawkish Federal Reserve commentary and rising rate-hike expectations are driving a sharp selloff in SoFi, with traders focused on the companys sensitivity to interest rates. The community is split between bears who see further pressure and bulls who argue that potential hikes are already reflected in guidance and view the decline as a buying opportunity.

Corvex, Inc. is an AI cloud computing company, which specializes in GPU-accelerated infrastructure for AI workloads. Its products include GPU Clusters, Confidential Computing, Inference as a Service and GPU Node. The firm offers solutions include AI model builders, enterprises, federal and sovereign solutions. The company was founded by Seth Mitchell Demsey, Jay Crystal on October 21, 2024 and is headquartered in Arlington, VA.

Corvex Inc.

Movano Inc

A multi-year agreement to provide NVIDIA Blackwell GPU clusters to an AI infrastructure customer, alongside Corvexs data-center expansion and merger with Movano, is driving attention. Traders are broadly bullish on the AI-infrastructure pivot and potential low-float short squeeze, while skeptics cite execution uncertainty and substantial dilution risk from financing and the merger structure.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Geopolitical supply riskespecially uncertainty around the Strait of Hormuz and U.S.-Iran tensionsis driving attention to Chevron as traders assess the impact of volatile crude prices on upstream cash flow. The community is divided between bulls expecting continued energy strength and bears warning that a peace deal or reopening of shipping routes could unwind the oil-risk premium; Chevrons potential Venezuela expansion is a secondary theme.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStops preliminary second-quarter update and amended convertible-note exchange, which caps potential share issuance and substitutes cash for further dilution, are driving attention alongside unusual activity in its warrants. Traders are divided between viewing improved operating profitability and reduced dilution as bullish, and focusing on weaker sales, remaining debt, and skepticism that a short squeeze will follow.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernovas mixed second-quarter reportan earnings miss despite stronger revenue, record backlog, and raised full-year guidancehas driven a sharp selloff and intense debate. Traders are split between viewing the decline as an overreaction and buying opportunity, while bears cite valuation, wind-segment losses, tariffs, and concerns that AI data-center demand is already priced in.

Pinterest, Inc. engages in the operation of a pinboard-style photo-sharing website. It allows users to create and manage theme-based image collections such as events, interests, and hobbies. The company was founded by Benjamin Silbermann, Paul Cahill Sciarra, and Evan Sharp in October 2008 and is headquartered in San Francisco, CA.

Pinterest Inc - Ordinary Shares - Class A

Pinterest Inc

Pinterest is drawing attention after CFO Julia Donnelly announced her departure for an early-stage company, prompting concerns about leadership continuity and slower growth. Traders view the selloff as either an overreaction, noting the interim CFO and stated lack of operational or accounting disagreement, or a sign of added uncertainty.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

Escalating U.S.-Iran tensions and uncertainty around Strait of Hormuz shipping are driving oil-supply concerns, depleted strategic reserves, and renewed attention to energy equities. Traders are divided between bullish views that prolonged disruption supports XLE and caution that a ceasefire or reopening could unwind the geopolitical premium and pressure the overbought sector.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ais quarterly results and FY2027 outlook are driving attention, with continued revenue weakness and a restructuring under returning founder Thomas Siebel, whose large personal share purchase is viewed by bulls as a vote of confidence. Traders are divided between a potential short squeeze fueled by elevated short interest and options activity, and bearish concerns about sales execution, cash burn, and the companys ability to deliver a turnaround.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Geopolitical tensions involving Iran and disruptions or potential restrictions around the Strait of Hormuz are driving attention to ExxonMobil through their impact on crude prices and energy-sector risk premiums. Traders are divided between expecting continued supply tightness and higher oil prices, and anticipating de-escalation or a ceasefire that could unwind the premium and pressure XOM; recent strong earnings and cash generation add to the discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MiNK Therapeutics (INKT) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

MiNK Therapeutics Q2 2026 Earnings Call: Complete Transcript

MiNK Therapeutics (NASDAQ:INKT) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call.
This transcript is brought to you by Benzinga APIs. For real-time access toread more...

Here's Why You Should Add INKT Stock to Your Portfolio Now

MiNK advances agenT-797 across respiratory, oncology and immune disease studies while expanding its next-generation engineered iNKT pipeline.

A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company

A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company PR Newswire SAN FRANCISCO, June 2, 2026 Equity Insider News CommentaryIssued on behalf of GT Biopharma, Inc. (NASDAQ: GTBP)SAN FRANCISCO, June 2...

Agenus Presents Phase 2 BOT+BAL Melanoma Data Showing Durable Responses and Meaningful Survival in Advanced Checkpoint-Refractory Melanoma at ASCO 2026

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the first disclosure of Phase 2 data from the C-800-23 study evaluating botensilimab (BOT), Agenus multifunctional Fc-enhanced anti-CTLA-4 antibody, with balstilimab (BAL), an anti-PD-1 antibody, in patients with...

Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced new retrospective data showing that Noetiks artificial intelligence-based TARIO-2 model identified spatial tumor microenvironment patterns associated with clinical outcomes from routine pretreatment tumor pathology...

Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the publication of Phase 1b data evaluating botensilimab (BOT), an Fc-enhanced anti-CTLA-4 antibody, in combination...

Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today reported financial results for the first quarter ended March 31, 2026, and provided an operational update on botensilimab...

MiNK Therapeutics, Inc. (NASDAQ:INKT) Given Consensus Recommendation of "Hold" by Analysts

MiNK Therapeutics, Inc. (NASDAQ:INKT - Get Free Report) has received an average rating of "Hold" from the five analysts that are presently covering the company, Marketbeat.com reports. One analyst...

Short Interest in MiNK Therapeutics, Inc. (NASDAQ:INKT) Drops By 30.6%

MiNK Therapeutics, Inc. (NASDAQ:INKT - Get Free Report) was the target of a significant decline in short interest in April. As of April 15th, there was short interest totaling 96,493 shares, a...

MiNK Therapeutics reported a net loss of $3.1 million, or $0.62 per share, for the second quarter of 2026, with cash and cash equivalents totaling $8.8 million as of June 30.

MiNK Therapeutics faces financial pressure from a net loss and declining cash reserves, while the clinical program remains in preliminary stages without regulatory approval or confirmed efficacy for agenT-797.

MiNK Therapeutics advanced its lead candidate into randomized clinical trials with positive initial observations and launched a strategic international access program to generate revenue and build scalable infrastructure for agenT-797.

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded by Garo H. Armen in 2017 and is headquartered in New York, NY.

MiNK Therapeutics Inc

Why Did INKT Stock Jump 30% Today?

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.35	--	--	N/A
Q2 '26	-$0.60	-$0.62	-3.33%	MISSED
Q1 '26	-$0.77	-$0.57	25.97%	BEAT
Q4 '25	-$0.68	-$0.52	23.53%	BEAT
Q3 '25	-$0.86	-$0.65	23.98%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings